Discovering tumor suppressor genes through genome-wide copy number analysis

Current Genomics

Volumn 11, Issue 5, 2010, Pages 297-310

  Rothenberg, S Michael ^a   Settleman, Jeff ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Array CGH; Cancer; Copy number analysis; Tumor suppressor genes

Indexed keywords

APC PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; FRAGILE HISTIDINE TRIAD PROTEIN; KRUPPEL LIKE FACTOR 6; PROTEIN KINASE LKB1; PROTEIN MSH2; PROTEIN P53; SMAD4 PROTEIN; TRANSCRIPTION FACTOR PAX5; WT1 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DNA MICROARRAY; EXON; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC LINKAGE; GERMLINE MICRONUCLEUS; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; LUNG ADENOCARCINOMA; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 77956502467     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920210791616734     Document Type: Article

References (85)

1. Bishop, J.M.; Baker, B.; Fujita, D.; McCombe, P.; Sheiness, D.; Smith, K.; Spector, D.H.; Stehelin, D.; Varmus, H.E. Genesis of a virus-transforming gene. Natl Cancer Inst. Monogr., 1978, (48), 219-223.
2. Druker, B.J.; Talpaz, M.; Resta, D.J.; Peng, B.; Buchdunger, E.; Ford, J.M.; Lydon, N.B.; Kantarjian, H.; Capdeville, R.; OhnoJones, S.; Sawyers, C.L. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med., 2001, 344, 1031-1037.
3. Lynch, T.J.; Bell, D.W.; Sordella, R.; Gurubhagavatula, S.; Okimoto, R.A.; Brannigan, B.W.; Harris, P.L.; Haserlat, S.M.; Supko, J.G.; Haluska, F.G.; Louis, D.N.; Christiani, D.C.; Settleman, J.; Haber, D.A. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med., 2004, 350, 2129-2139.
4. Paez, J.G.; Janne, P.A.; Lee, J.C.; Tracy, S.; Greulich, H.; Gabriel, S.; Herman, P.; Kaye, F.J.; Lindeman, N.; Boggon, T.J.; Naoki, K.; Sasaki, H.; Fujii, Y.; Eck, M.J.; Sellers, W.R.; Johnson, B.E.; Meyerson, M. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science, 2004, 304, 1497-1500.
5. Pao, W.; Miller, V.; Zakowski, M.; Doherty, J.; Politi, K.; Sarkaria, I.; Singh, B.; Heelan, R.; Rusch, V.; Fulton, L.; Mardis, E.; Kupfer, D.; Wilson, R.; Kris, M.; Varmus, H. EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc. Natl. Acad. Sci. USA, 2004, 101, 13306-13311.
6. Slamon, D.J.; Leyland-Jones, B.; Shak, S.; Fuchs, H.; Paton, V.; Bajamonde, A.; Fleming, T.; Eiermann, W.; Wolter, J.; Pegram, M.; Baselga, J.; Norton, L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med., 2001, 344, 783-792.
7. Vogel, C.; Cobleigh, M.A.; Tripathy, D.; Gutheil, J.C.; Harris, L.N.; Fehrenbacher, L.; Slamon, D.J.; Murphy, M.; Novotny, W.F.; Burchmore, M.; Shak, S.; Stewart, S.J. First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report. Eur. J. Cancer, 2001, 37(Suppl 1), S25-29.
8. Lisitsyn, N.; Wigler, M. Cloning the differences between two complex genomes. Science, 1993, 259, 946-951.
9. Nelson, S.F.; McCusker, J.H.; Sander, M.A.; Kee, Y.; Modrich, P.; Brown, P.O. Genomic mismatch scanning: a new approach to genetic linkage mapping. Nat. Genet., 1993, 4, 11-18.
10. Pinkel, D.; Segraves, R.; Sudar, D.; Clark, S.; Poole, I.; Kowbel, D.; Collins, C.; Kuo, W.L.; Chen, C.; Zhai, Y.; Dairkee, S.H.; Ljung, B.M.; Gray, J.W.; Albertson, D.G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet., 1998, 20, 207-211.
11. Pollack, J.R.; Perou, C.M.; Alizadeh, A.A.; Eisen, M.B.; Pergamenschikov, A.; Williams, C.F.; Jeffrey, S.S.; Botstein, D.; Brown, P.O. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet., 1999, 23, 41-46.
12. Call, K.M.; Glaser, T.; Ito, C.Y.; Buckler, A.J.; Pelletier, J.; Haber, D.A.; Rose, E.A.; Kral, A.; Yeger, H.; Lewis, W.H.; et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 1990, 60, 509-520.
13. Dryja, T.P.; Rapaport, J.M.; Joyce, J.M.; Petersen, R.A. Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. Proc. Natl. Acad. Sci. USA, 1986, 83, 7391-7394.
14. Groden, J.; Thliveris, A.; Samowitz, W.; Carlson, M.; Gelbert, L.; Albertsen, H.; Joslyn, G.; Stevens, J.; Spirio, L.; Robertson, M.; Sargeant, L.; Krapcho, K.; Wolff, E.; Burt, R.; Hughes, J.P.; Warrington, J.; McPherson, J.; Wasmuth, J.; Le Paslier, D.; Abderrahim, H.; Cohen, D.; Leppert, M.; White, R. Identification and characterization of the familial adenomatous polyposis coligene. Cell, 1991, 66, 589-600.
15. Haber, D.A.; Buckler, A.J.; Glaser, T.; Call, K.M.; Pelletier, J.; Sohn, R.L.; Douglass, E.C.; Housman, D.E. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell, 1990, 61, 1257-1269.
16. Joslyn, G.; Carlson, M.; Thliveris, A.; Albertsen, H.; Gelbert, L.; Samowitz, W.; Groden, J.; Stevens, J.; Spirio, L.; Robertson, M.; Sargeant, L.; Krapcho, K.; Wolff, E.; Burt, R.; Hughes, J.P.; Warrington, J.; McPherson, J.; Wasmuth, J.; Le Paslier, D.; Abderrahim, H.; Cohen, D.; Leppert, M.; White, R. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell, 1991, 66, 601-613.
17. Kamb, A.; Gruis, N.A.; Weaver-Feldhaus, J.; Liu, Q.; Harshman, K.; Tavtigian, S.V.; Stockert, E.; Day, R.S.; 3rd, Johnson, B.E.; Skolnick, M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 1994, 264, 436-440.
18. Li, J.; Yen, C.; Liaw, D.; Podsypanina, K.; Bose, S.; Wang, S.I.; Puc, J.; Miliaresis, C.; Rodgers, L.; McCombie, R.; Bigner, S.H.; Giovanella, B.C.; Ittmann, M.; Tycko, B.; Hibshoosh, H.; Wigler, M.H.; Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275, 1943-1947.
19. Rivera, M.N.; Kim, W.J.; Wells, J.; Driscoll, D.R.; Brannigan, B.W.; Han, M.; Kim, J.C.; Feinberg, A.P.; Gerald, W.L.; Vargas, S.O.; Chin, L.; Iafrate, A.J.; Bell, D.W.; Haber, D.A. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science, 2007, 315, 642-645.
20. Steck, P.A.; Pershouse, M.A.; Jasser, S.A.; Yung, W.K.; Lin, H.; Ligon, A.H.; Langford, L.A.; Baumgard, M.L.; Hattier, T.; Davis, T.; Frye, C.; Hu, R.; Swedlund, B.; Teng, D.H.; Tavtigian, S.V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 1997, 15, 356-362.
21. Thiagalingam, S.; Lengauer, C.; Leach, F.S.; Schutte, M.; Hahn, S.A.; Overhauser, J.; Willson, J.K.; Markowitz, S.; Hamilton, S.R.; Kern, S.E.; Kinzler, K.W.; Vogelstein, B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet., 1996, 13, 343-346.
22. Weaver-Feldhaus, J.; Gruis, N.A.; Neuhausen, S.; Le Paslier, D.; Stockert, E.; Skolnick, M.H.; Kamb, A. Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc. Natl. Acad. Sci. USA, 1994, 91, 7563-7567.
23. Zhao, X.; Li, C.; Paez, J.G.; Chin, K.; Janne, P.A.; Chen, T.H.; Girard, L.; Minna, J.; Christiani, D.; Leo, C.; Gray, J.W.; Sellers, W.R.; Meyerson, M. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res., 2004, 64, 3060-3071.
24. Schutte, M.; da Costa, L.T.; Hahn, S.A.; Moskaluk, C.; Hoque, A.T.; Rozenblum, E.; Weinstein, C.L.; Bittner, M.; Meltzer, P.S.; Trent, J.M.; Yeo, C.J.; Hruban, R.H.; Kern, S.E. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA, 1995, 92, 5950-5954.
25. Yajnik, V.; Paulding, C.; Sordella, R.; McClatchey, A.I.; Saito, M.; Wahrer, D.C.; Reynolds, P.; Bell, D.W.; Lake, R.; van den Heuvel, S.; Settleman, J.; Haber, D.A. DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell, 2003, 112, 673-684.
26. Lucito, R.; Healy, J.; Alexander, J.; Reiner, A.; Esposito, D.; Chi, M.; Rodgers, L.; Brady, A.; Sebat, J.; Troge, J.; West, J.A.; Rostan, S.; Nguyen, K.C.; Powers, S.; Ye, K.Q.; Olshen, A.; Venkatraman, E.; Norton, L.; Wigler, M. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res., 2003, 13, 2291-2305.
27. Kallioniemi, A.; Kallioniemi, O.P.; Sudar, D.; Rutovitz, D.; Gray, J.W.; Waldman, F.; Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science, 1992, 258, 818-821.
28. Schrock, E.; du Manoir, S.; Veldman, T.; Schoell, B.; Wienberg, J.; Ferguson-Smith, M.A.; Ning, Y.; Ledbetter, D.H.; Bar-Am, I.; Soenksen, D.; Garini, Y.; Ried, T. Multicolor spectral karyotyping of human chromosomes. Science, 1996, 273, 494-497.
29. Lockhart, D.J.; Dong, H.; Byrne, M.C.; Follettie, M.T.; Gallo, M.V.; Chee, M.S.; Mittmann, M.; Wang, C.; Kobayashi, M.; Horton, H.; Brown, E.L. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol., 1996, 14, 1675-1680.
30. Schena, M.; Shalon, D.; Davis, R.W.; Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 1995, 270, 467-470.
31. Geschwind, D.H.; Gregg, J.; Boone, K.; Karrim, J.; Pawlikowska-Haddal, A.; Rao, E.; Ellison, J.; Ciccodicola, A.; D'Urso, M.; Woods, R.; Rappold, G.A.; Swerdloff, R.; Nelson, S.F. Klinefelter's syndrome as a model of anomalous cerebral laterality: testing gene dosage in the X chromosome pseudoautosomal region using a DNA microarray. Dev. Genet., 1998, 23, 215-229.
32. Solinas-Toldo, S.; Lampel, S.; Stilgenbauer, S.; Nickolenko, J.; Benner, A.; Dohner, H.; Cremer, T.; Lichter, P. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer, 1997, 20, 399-407.
33. Lindblad-Toh, K.; Tanenbaum, D.M.; Daly, M.J.; Winchester, E.; Lui, W.O.; Villapakkam, A.; Stanton, S.E.; Larsson, C.; Hudson, T.J.; Johnson, B.E.; Lander, E.S.; Meyerson, M. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat. Biotechnol., 2000, 18, 1001-1005.
34. Wang, T.L.; Maierhofer, C.; Speicher, M.R.; Lengauer, C.; Vogelstein, B.; Kinzler, K.W.; Velculescu, V.E. Digital karyotyping. Proc. Natl. Acad. Sci. USA, 2002, 99, 16156-16161.
35. Nakayama, K.; Nakayama, N.; Davidson, B.; Katabuchi, H.; Kurman, R.J.; Velculescu, V.E.; Shih Ie, M.; Wang, T.L. Homozygous deletion of MKK4 in ovarian serous carcinoma. Cancer Biol. Ther., 2006, 5, 630-634.
36. Chiang, D.Y.; Getz, G.; Jaffe, D.B.; O'Kelly, M.J.; Zhao, X.; Carter, S.L.; Russ, C.; Nusbaum, C.; Meyerson, M.; Lander, E.S. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat. Methods, 2009, 6, 99-103.
37. Li, C.; Wong, W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA, 2001, 98, 31-36.
38. Taylor, B.S.; Barretina, J.; Socci, N.D.; Decarolis, P.; Ladanyi, M.; Meyerson, M.; Singer, S.; Sander, C. Functional copy-number alterations in cancer. PLoS One, 2008, 3, e3179.
39. Autio, R.; Hautaniemi, S.; Kauraniemi, P.; Yli-Harja, O.; Astola, J.; Wolf, M.; Kallioniemi, A. CGH-Plotter: MATLAB toolbox for CGH-data analysis. Bioinformatics, 2003, 19, 1714-1715.
40. Heidenblad, M.; Schoenmakers, E.F.; Jonson, T.; Gorunova, L.; Veltman, J.A.; van Kessel, A.G.; Hoglund, M. Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines. Cancer Res., 2004, 64, 3052-3059.
41. Hodgson, G.; Hager, J.H.; Volik, S.; Hariono, S.; Wernick, M.; Moore, D.; Nowak, N.; Albertson, D.G.; Pinkel, D.; Collins, C.; Hanahan, D.; Gray, J.W. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet., 2001, 29, 459-464.
42. Hupe, P.; Stransky, N.; Thiery, J.P.; Radvanyi, F.; Barillot, E. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics, 2004, 20, 3413-3422.
43. Linn, S.C.; West, R.B.; Pollack, J.R.; Zhu, S.; Hernandez-Boussard, T.; Nielsen, T.O.; Rubin, B.P.; Patel, R.; Goldblum, J.R.; Siegmund, D.; Botstein, D.; Brown, P.O.; Gilks, C.B.; van de Rijn, M. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Am. J. Pathol., 2003, 163, 2383-2395.
44. Olshen, A.B.; Venkatraman, E.S.; Lucito, R.; Wigler, M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics, 2004, 5, 557-572.
45. Pollack, J.R.; Sorlie, T.; Perou, C.M.; Rees, C.A.; Jeffrey, S.S.; Lonning, P.E.; Tibshirani, R.; Botstein, D.; Borresen-Dale, A.L.; Brown, P.O. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. USA, 2002, 99, 12963-12968.
46. Price, T.S.; Regan, R.; Mott, R.; Hedman, A.; Honey, B.; Daniels, R.J.; Smith, L.; Greenfield, A.; Tiganescu, A.; Buckle, V.; Ventress, N.; Ayyub, H.; Salhan, A.; Pedraza-Diaz, S.; Broxholme, J.; Ragoussis, J.; Higgs, D.R.; Flint, J.; Knight, S.J. SW-ARRAY: a dynamic programming solution for the identification of copy-number changes in genomic DNA using array comparative genome hybridization data. Nucleic Acids Res., 2005, 33, 3455-3464.
47. Snijders, A.M.; Fridlyand, J.; Mans, D.A.; Segraves, R.; Jain, A.N.; Pinkel, D.; Albertson, D.G. Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene, 2003, 22, 4370-4379.
48. Wang, P.; Kim, Y.; Pollack, J.; Narasimhan, B.; Tibshirani, R. A method for calling gains and losses in array CGH data. Biostatistics, 2005, 6, 45-58.
49. Weiss, M.M.; Snijders, A.M.; Kuipers, E.J.; Ylstra, B.; Pinkel, D.; Meuwissen, S.G.; van Diest, P.J.; Albertson, D.G.; Meijer, G.A. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J. Pathol., 2003, 200, 320-326.
50. Aguirre, A.J.; Brennan, C.; Bailey, G.; Sinha, R.; Feng, B.; Leo, C.; Zhang, Y.; Zhang, J.; Gans, J.D.; Bardeesy, N.; Cauwels, C.; Cordon-Cardo, C.; Redston, M.S.; DePinho, R.A.; Chin, L. High-resolution characterization of the pancreatic adenocarcinoma genome. Proc. Natl. Acad. Sci. USA, 2004, 101, 9067-9072.
51. Beroukhim, R.; Getz, G.; Nghiemphu, L.; Barretina, J.; Hsueh, T.; Linhart, D.; Vivanco, I.; Lee, J.C.; Huang, J.H.; Alexander, S.; Du, J.; Kau, T.; Thomas, R.K.; Shah, K.; Soto, H.; Perner, S.; Prensner, J.; Debiasi, R.M.; Demichelis, F.; Hatton, C.; Rubin, M.A.; Garraway, L.A.; Nelson, S.F.; Liau, L.; Mischel, P.S.; Cloughesy, T.F.; Meyerson, M.; Golub, T.A.; Lander, E.S.; Mellinghoff, I.K.; Sellers, W.R. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. USA, 2007, 104, 20007-20012.
52. Weir, B.A.; Woo, M.S.; Getz, G.; Perner, S.; Ding, L.; Beroukhim, R.; Lin, W.M.; Province, M.A.; Kraja, A.; Johnson, L.A.; Shah, K.; Sato, M.; Thomas, R.K.; Barletta, J.A.; Borecki, I.B.; Broderick, S.; Chang, A.C.; Chiang, D.Y.; Chirieac, L.R.; Cho, J.; Fujii, Y.; Gazdar, A.F.; Giordano, T.; Greulich, H.; Hanna, M.; Johnson, B.E.; Kris, M.G.; Lash, A.; Lin, L.; Lindeman, N.; Mardis, E.R.; McPherson, J.D.; Minna, J.D.; Morgan, M.B.; Nadel, M.; Orringer, M.B.; Osborne, J.R.; Ozenberger, B.; Ramos, A.H.; Robinson, J.; Roth, J.A.; Rusch, V.; Sasaki, H.; Shepherd, F.; Sougnez, C.; Spitz, M.R.; Tsao, M.S.; Twomey, D.; Verhaak, R.G.; Weinstock, G.M.; Wheeler, D.A.; Winckler, W.; Yoshizawa, A.; Yu, S.; Zakowski, M.F.; Zhang, Q.; Beer, D.G.; Wistuba, II.; Watson, M.A.; Garraway, L.A.; Ladanyi, M.; Travis, W.D.; Pao, W.; Rubin, M.A.; Gabriel, S.B.; Gibbs, R.A.; Varmus, H.E.; Wilson, R.K.; Lander, E.S.; Meyerson, M. Characterizing the cancer genome in lung adenocarcinoma. Nature, 2007, 450, 893-898.
53. Rouveirol, C.; Stransky, N.; Hupe, P.; Rosa, P.L.; Viara, E.; Barillot, E.; Radvanyi, F. Computation of recurrent minimal genomic al-terations from array-CGH data. Bioinformatics, 2006, 22, 849-856.
54. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 2008,455, 1061-1068.
55. Iafrate, A.J.; Feuk, L.; Rivera, M.N.; Listewnik, M.L.; Donahoe, P.K.; Qi, Y.; Scherer, S.W.; Lee, C. Detection of large-scale variation in the human genome. Nat Genet., 2004, 36(9), 949-51.
56. McCarroll, S.A.; Kuruvilla, F.G.; Korn, J.M.; Cawley, S.; Nemesh, J.; Wysoker, A.; Shapero, M.H.; de Bakker, P.I.; Maller, J.B.; Kirby, A.; Elliott, A.L.; Parkin, M.; Hubbell, E.; Webster, T.; Mei, R.; Veitch, J.; Collins, P.J.; Handsaker, R.; Lincoln, S.; Nizzari, M.; Blume, J.; Jones, K.W.; Rava, R.; Daly, M.J.; Gabriel, S.B.; Altshuler, D. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat. Genet., 2008, 40, 1166-1174.
57. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature, 2008,455, 237-241.
58. McCarroll, S.A.; Huett, A.; Kuballa, P.; Chilewski, S.D.; Landry, A.; Goyette, P.; Zody, M.C.; Hall, J.L.; Brant, S.R.; Cho, J.H.; Duerr, R.H.; Silverberg, M.S.; Taylor, K.D.; Rioux, J.D.; Altshuler, D.; Daly, M.J.; Xavier, R.J. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet., 2008, 40(9), 1107-12.
59. Stefansson, H.; Rujescu, D.; Cichon, S.; Pietilainen, O.P.; Ingason, A.; Steinberg, S.; Fossdal, R.; Sigurdsson, E.; Sigmundsson, T.; Buizer-Voskamp, J.E.; Hansen, T.; Jakobsen, K.D.; Muglia, P.; Francks, C.; Matthews, P.M.; Gylfason, A.; Halldorsson, B.V.; Gudbjartsson, D.; Thorgeirsson, T.E.; Sigurdsson, A.; Jonasdottir, A.; Bjornsson, A.; Mattiasdottir, S.; Blondal, T.; Haraldsson, M.; Magnusdottir, B.B.; Giegling, I.; Moller, H.J.; Hartmann, A.; Shianna, K.V.; Ge, D.; Need, A.C.; Crombie, C.; Fraser, G.; Walker, N.; Lonnqvist, J.; Suvisaari, J.; Tuulio-Henriksson, A.; Paunio, T.; Toulopoulou, T.; Bramon, E.; Di Forti, M.; Murray, R.; Ruggeri, M.; Vassos, E.; Tosato, S.; Walshe, M.; Li, T.; Vasilescu, C.; Muhleisen, T.W.; Wang, A.G.; Ullum, H.; Djurovic, S.; Melle, I.; Olesen, J.; Kiemeney, L.A.; Franke, B.; Sabatti, C.; Freimer, N.B.; Gulcher, J.R.; Thorsteinsdottir, U.; Kong, A.; Andreassen, O.A.; Ophoff, R.A.; Georgi, A.; Rietschel, M.; Werge, T.; Petursson, H.; Goldstein, D.B.; Nothen, M.M.; Peltonen, L.; Collier, D.A.; St Clair, D.; Stefansson, K. Large recurrent microdeletions associated with schizophrenia. Nature, 2008, 455, 232-236.
60. Bashyam, M.D.; Bair, R.; Kim, Y.H.; Wang, P.; Hernandez-Boussard, T.; Karikari, C.A.; Tibshirani, R.; Maitra, A.; Pollack, J.R. Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia, 2005, 7, 556-562.
61. Rubin, A.F.; Green, P. Comment on The consensus coding sequences of human breast and colorectal cancers. Science, 2007, 317, 1500.
62. Greenman, C.; Stephens, P.; Smith, R.; Dalgliesh, G.L.; Hunter, C.; Bignell, G.; Davies, H.; Teague, J.; Butler, A.; Stevens, C.; Edkins, S.; O'Meara, S.; Vastrik, I.; Schmidt, E.E.; Avis, T.; Barthorpe, S.; Bhamra, G.; Buck, G.; Choudhury, B.; Clements, J.; Cole, J.; Dicks, E.; Forbes, S.; Gray, K.; Halliday, K.; Harrison, R.; Hills, K.; Hinton, J.; Jenkinson, A.; Jones, D.; Menzies, A.; Mironenko, T.; Perry, J.; Raine, K.; Richardson, D.; Shepherd, R.; Small, A.; Tofts, C.; Varian, J.; Webb, T.; West, S.; Widaa, S.; Yates, A.; Cahill, D.P.; Louis, D.N.; Goldstraw, P.; Nicholson, A.G.; Brasseur, F.; Looijenga, L.; Weber, B.L.; Chiew, Y.E.; DeFazio, A.; Greaves, M.F.; Green, A.R.; Campbell, P.; Birney, E.; Easton, D.F.; Chenevix-Trench, G.; Tan, M.H.; Khoo, S.K.; Teh, B.T.; Yuen, S.T.; Leung, S.Y.; Wooster, R.; Futreal, P.A.; Stratton, M.R. Patterns of somatic mutation in human cancer genomes. Nature, 2007, 446, 153-158.
63. Getz, G.; Hofling, H.; Mesirov, J.P.; Golub, T.R. Meyerson, M.; Tibshirani, R.; Lander, E.S. Comment on The consensus coding sequences of human breast and colorectal cancers. Science, 2007, 317, 1500.
64. Forrest, W.F.; Cavet, G. Comment on The consensus coding sequences of human breast and colorectal cancers. Science, 2007, 317, 1500; author reply 1500.
65. Sjoblom, T.; Jones, S.; Wood, L.D.; Parsons, D.W.; Lin, J.; Barber, T.D.; Mandelker, D.; Leary, R.J.; Ptak, J.; Silliman, N.; Szabo, S.; Buckhaults, P.; Farrell, C.; Meeh, P.; Markowitz, S.D.; Willis, J.; Dawson, D.; Willson, J.K.; Gazdar, A.F.; Hartigan, J.; Wu, L.; Liu, C.; Parmigiani, G.; Park, B.H.; Bachman, K.E.; Papadopoulos, N.; Vogelstein, B.; Kinzler, K.W.; Velculescu, V.E. The consensus coding sequences of human breast and colorectal cancers. Science, 2006, 314, 268-274.
66. Bignell, G.R.; Greenman, C.D.; Davies, H.; Butler, A.P.; Edkins, S.; Andrews, J.M.; Buck, G.; Chen, L.; Beare, D.; Latimer, C.; Widaa, S.; Hinton, J.; Fahey, C.; Fu, B.; Swamy, S.; Dalgliesh, G.L.; Teh, B.T.; Deloukas, P.; Yang, F.; Campbell, P.J.; Futreal, P.A.; Stratton, M.R. Signatures of mutation and selection in the cancer genome. Nature, 2010, 463, 893-898.
67. Cox, C.; Bignell, G.; Greenman, C.; Stabenau, A.; Warren, W.; Stephens, P.; Davies, H.; Watt, S.; Teague, J.; Edkins, S.; Birney, E.; Easton, D.F.; Wooster, R.; Futreal, P.A.; Stratton, M.R. A survey of homozygous deletions in human cancer genomes. Proc. Natl. Acad. Sci. USA, 2005, 102, 4542-4547.
68. Diskin, S.J.; Eck, T.; Greshock, J.; Mosse, Y.P.; Naylor, T.; Stoeckert Jr., C.J.;Weber, B.L.; Maris, J.M.; Grant, G.R. STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments. Genome Res., 2006, 16, 1149-1158.
69. Kim, T.M.; Jung, Y.C.; Rhyu, M.G.; Jung, M.H.; Chung, Y.J. GEAR: genomic enrichment analysis of regional DNA copy number changes. Bioinformatics, 2008, 24, 420-421.
70. Beroukhim, R.; Brunet, J.P.; Di Napoli, A.; Mertz, K.D.; Seeley, A.; Pires, M.M.; Linhart, D.; Worrell, R.A.; Moch, H.; Rubin, M.A.; Sellers, W.R.; Meyerson, M.; Linehan, W.M.; Kaelin Jr., W.G.; Signoretti, S. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res., 2009, 69, 4674-4681.
71. Kotliarov, Y.; Steed, M.E.; Christopher, N.; Walling, J.; Su, Q.; Center, A.; Heiss, J.; Rosenblum, M.; Mikkelsen, T.; Zenklusen, J.C.; Fine, H.A. High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res., 2006, 66, 9428-9436.
72. Maher, E.A.; Brennan, C.; Wen, P.Y.; Durso, L.; Ligon, K.L.; Richardson, A.; Khatry, D.; Feng, B.; Sinha, R.; Louis, D.N.; Quackenbush, J.; Black, P.M.; Chin, L.; DePinho, R.A. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. Cancer Res., 2006, 66, 11502-11513.
73. Kitada, T.; Asakawa, S.; Hattori, N.; Matsumine, H.; Yamamura, Y.; Minoshima, S.; Yokochi, M.; Mizuno, Y.; Shimizu, N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 1998, 392, 605-608.
74. Cesari, R.; Martin, E.S.; Calin, G.A.; Pentimalli, F.; Bichi, R.; McAdams, H.; Trapasso, F.; Drusco, A.; Shimizu, M.; Masciullo, V.; D'Andrilli, G.; Scambia, G.; Picchio, M.C.; Alder, H.; Godwin, A.K.; Croce, C.M. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc. Natl. Acad. Sci. USA, 2003, 100, 5956-5961.
75. Denison, S.R.; Wang, F.; Becker, N.A.; Schule, B.; Kock, N.; Phillips, L.A.; Klein, C.; Smith, D.I. Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene, 2003, 22, 8370-8378.
76. Wang, F.; Denison, S.; Lai, J.P.; Philips, L.A.; Montoya, D.; Kock, N.; Schule, B.; Klein, C.; Shridhar, V.; Roberts, L.R.; Smith, D.I. Parkin gene alterations in hepatocellular carcinoma. Genes Chromosomes Cancer, 2004, 40, 85-96.
77. Veeriah, S.; Taylor, B.S.; Meng, S.; Fang, F.; Yilmaz, E.; Vivanco, I.; Janakiraman, M.; Schultz, N.; Hanrahan, A.J.; Pao, W.; Ladanyi, M.; Sander, C.; Heguy, A.; Holland, E.C.; Paty, P.B.; Mischel, P.S.; Liau, L.; Cloughesy, T.F.; Mellinghoff, I.K.; Solit, D.B.; Chan, T.A. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat. Genet., 2010, 42, 77-82.
78. Sato, M.; Takahashi, K.; Nagayama, K.; Arai, Y.; Ito, N.; Okada, M.; Minna, J.D.; Yokota, J.; Kohno, T. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer. Genes Chromosomes Cancer, 2005, 44, 405-414.
79. Zhao, X.; Weir, B.A.; LaFramboise, T.; Lin, M.; Beroukhim, R.; Garraway, L.; Beheshti, J.; Lee, J.C.; Naoki, K.; Richards, W.G.; Sugarbaker, D.; Chen, F.; Rubin, M.A.; Janne, P.A.; Girard, L.; Minna, J.; Christiani, D.; Li, C.; Sellers, W.R.; Meyerson, M. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res., 2005, 65, 5561-5570.
80. Rivera, M.N.; Haber, D.A. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat. Rev. Cancer, 2005, 5, 699-712.
81. van Haaften, G.; Dalgliesh, G.L.; Davies, H.; Chen, L.; Bignell, G.; Greenman, C.; Edkins, S.; Hardy, C.; O'Meara, S.; Teague, J.; Butler, A.; Hinton, J.; Latimer, C.; Andrews, J.; Barthorpe, S.; Beare, D.; Buck, G.; Campbell, P.J.; Cole, J.; Forbes, S.; Jia, M.; Jones, D.; Kok, C.Y.; Leroy, C.; Lin, M.L.; McBride, D.J.; Maddison, M.; Maquire, S.; McLay, K.; Menzies, A.; Mironenko, T.; Mulderrig, L.; Mudie, L.; Pleasance, E.; Shepherd, R.; Smith, R.; Stebbings, L.; Stephens, P.; Tang, G.; Tarpey, P.S.; Turner, R.; Turrell, K.; Varian, J.; West, S.; Widaa, S.; Wray, P.; Collins, V.P.; Ichimura, K.; Law, S.; Wong, J.; Yuen, S.T.; Leung, S.Y.; Tonon, G.; DePinho, R.A.; Tai, Y.T.; Anderson, K.C.; Kahnoski, R.J.; Massie, A.; Khoo, S.K.; Teh, B.T.; Stratton, M.R.; Futreal, P.A. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet., 2009, 41, 521-523.
82. Mullighan, C.G.; Goorha, S.; Radtke, I.; Miller, C.B.; Coustan-Smith, E.; Dalton, J.D.; Girtman, K.; Mathew, S.; Ma, J.; Pounds, S.B.; Su, X.; Pui, C.H.; Relling, M.V.; Evans, W.E.; Shurtleff, S.A.; Downing, J.R. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature, 2007, 446, 758-764.
83. Mullighan, C.G.; Miller, C.B.; Radtke, I.; Phillips, L.A.; Dalton, J.; Ma, J.; White, D.; Hughes, T.P.; Le Beau, M.M.; Pui, C.H.; Relling, M.V.; Shurtleff, S.A.; Downing, J.R. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature, 2008, 453, 110-114.
84. Cheok, M.H.; Evans, W.E. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. Nat. Rev. Cancer, 2006, 6, 117-129.
85. Rothenberg, S.M.; Mohapatra, G.; Rivera, M.N.; Winokur, D.; Greninger, P.; Nitta, M.; Sadow, P.M.; Sooriyakumar, G.; Brannigan, B.W.; Ulman, M.J.; Perera, R.M.; Wang, R.; Tam, A.; Ma, X.J.; Erlander, M.; Sgroi, D.C.; Rocco, J.W.; Lingen, M.W.; Cohen, E.E.; Louis, D.N.; Settleman, J.; Haber, D.A. A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. Cancer Res., 2010, 70, 2158-2164.